Price (delayed)
$1.41
Market cap
$16.49M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.09
Enterprise value
-$2.95M
Synlogic™ is bringing the transformative potential of synthetic biology to medicine. With a premiere synthetic biology platform that leverages a reproducible, modular approach to microbial engineering, Synlogic designs Synthetic Biotic
There are no recent dividends present for SYBX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.